This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Christopher Annunziato: Innovator in Immunosuppressant Research
Introduction
Christopher Annunziato is an accomplished inventor based in North Lawrence, NJ (US). He is currently associated with Bristol-Myers Squibb Company, where he contributes to the field of immunosuppressant research. Despite having no granted patents to his name, his work is significant in the development of new therapeutic compounds.
Latest Patent Applications
Christopher Annunziato has submitted several notable patent applications. One of his latest applications is titled "MACROCYCLIC PAD4 INHIBITORS USEFUL AS IMMUNOSUPPRESSANT." This invention provides compounds of Formula (I) that are useful as inhibitors of PAD4, along with compositions and methods for treating PAD4-related disorders. Another application is "SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS," which also focuses on compounds of Formula (I) for the same purpose.
Conclusion
Christopher Annunziato's contributions to immunosuppressant research through his patent applications highlight his innovative spirit and dedication to advancing medical science. His work at Bristol-Myers Squibb Company positions him as a key player in the development of new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile